The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Development of an IHC-based detection method for studying indoleamine 2,3-dioxygenase 1 (IDO1) expression in human cancers.
Alton Hiscox
Employment or Leadership Position - Ventana
Heather Gustafson
Employment or Leadership Position - Ventana
Joseph Couto
Employment or Leadership Position - Spring Bioscience
Zhiming Liao
Employment or Leadership Position - Spring Bioscience
Yifei Zhu
Employment or Leadership Position - Spring Bioscience
Xiangdong Liu
Employment or Leadership Position - Incyte
Stock Ownership - Incyte
Robert Charles Newton
Employment or Leadership Position - Incyte
Stock Ownership - Incyte
James Hnatyszyn
Employment or Leadership Position - Ventana
Stock Ownership - Roche